Evidence map›Paper›PMID 18033723›Full record

ArticleHuman mutation2008

Detailed analysis of 22q11.2 with a high density MLPA probe set.

G R Jalali, J A S Vorstman, Ab Errami, R Vijzelaar, J Biegel, T Shaikh, B S Emanuel

Open access · greenAbstract read
In one paragraph

Article in Human mutation, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 116 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. A Comprehensive Analysis of Cerebellar Volumes in the 22q11.2 Deletion Syndrome.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2023
    Article
  7. Article
  8. Article
  9. Genomic frontiers in congenital heart disease.Nature reviews. Cardiology · 2022
    Review
  10. Article
  11. Article
  12. Early language measures associated with later psychosis features in 22q11.2 deletion syndrome.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

G R JalaliDivision of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104-4318, USA.
J A S Vorstman
Ab Errami
R Vijzelaar
J Biegel
T Shaikh
B S Emanuel
Children's Hospital of Philadelphia · USMRC Holland (Netherlands) · NLUniversity of Pennsylvania · USUniversity Medical Center Utrecht · NL

Funding

Molecular Analysis of Human Subtelomeric RearrangementsP50HL074731 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI LEVY, ROBERT J · 2004 to 2008
$19.2M
CYTOGENETIC AND MOLECULAR STUDIES OF HUMAN CHROMOSOME 22R01CA039926 · NCI · CHILDREN'S HOSP OF PHILADELPHIA · PI EMANUEL, BEVERLY S · 1985 to 2013
$4.0M
Genetic Modifiers for 22q 11.2 Deletion SyndromeR01HL084410 · NHLBI · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI MORROW, BERNICE E · 2007 to 2010
$3.3M
NCI NIH HHS CA 39926NCI NIH HHS R01 CA039926NHLBI NIH HHS HL 74731NHLBI NIH HHS P50 HL074731NHLBI NIH HHS R01 HL084410
6 · The paper itself

Abstract

The presence of chromosome-specific low-copy repeats (LCRs) predisposes chromosome 22 to deletions and duplications. The current diagnostic procedure for detecting aberrations at 22q11.2 is chromosomal analysis coupled with fluorescence in situ hybridization (FISH) or PCR-based multiplex ligation dependent probe amplification (MLPA). However, there are copy number variations (CNVs) in 22q11.2 that are only detected by high-resolution platforms such as array comparative genomic hybridization (aCGH). We report on development of a high-definition MLPA (MLPA-HD) 22q11 kit that detects copy number changes at 37 loci on the long arm of chromosome 22. These include the 3-Mb region commonly deleted in DiGeorge/velocardiofacial syndrome (DGS/VCFS), the cat eye syndrome (CES) region, and more distal regions in 22q11 that have recently been shown to be deleted. We have used this MLPA-HD probe set to analyze 363 previously well-characterized samples with a variety of different rearrangements at 22q11 and demonstrate that it can detect copy number alterations with high sensitivity and specificity. In addition to detection of the common recurrent deletions associated with DGS/VCFS, variant and novel chromosome 22 aberrations have been detected. These include duplications within as well as deletions distal to this region. Further, the MLPA-HD detects deletion endpoint differences between patients with the common 3-Mb deletion. The MLPA-HD kit is proposed as a cost effective alternative to the currently available detection methods for individuals with features of the 22q11 aberrations. In patients with the relevant phenotypic characteristics, this MLPA-HD probe set could replace FISH for the clinical diagnosis of 22q11.2 deletions and duplications.

Indexed as

Molecular Probe TechniquesChromosome AberrationsChromosome DeletionChromosomes, Human, Pair 22ColobomaCraniofacial AbnormalitiesDiGeorge SyndromeGene DosageGenetic VariationHumansNucleic Acid Amplification TechniquesRhabdoid Tumor

Identifiers

PMID18033723
PMCPMC2664158
OpenAlexW2161574038

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.